Teriflunomide in patients with multiple sclerosis
The article discusses the prospects for the use of the new drug teriflunomide for the treatment of patients with relapsing-remitting multiple sclerosis. By now, phase II and III clinical trials are completed which demonstrated good tolerability, efficacy and relative safety of teriflunomide. The TEM...
I tiakina i:
| Ngā kaituhi matua: | , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Russo |
| I whakaputaina: |
Remedium Group LLC
2015-12-01
|
| Rangatū: | Медицинский совет |
| Ngā marau: | |
| Urunga tuihono: | https://www.med-sovet.pro/jour/article/view/177 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|